Macroscale delivery systems for molecular and cellular payloads.

Macroscale drug delivery (MDD) devices are engineered to exert spatiotemporal control over the presentation of a wide range of bioactive agents, including small molecules, proteins and cells. In contrast to systemically delivered drugs, MDD systems act as a depot of drug localized to the treatment site, which can increase drug effectiveness while reducing side effects and confer protection to labile drugs. In this Review, we highlight the key advantages of MDD systems, describe their mechanisms of spatiotemporal control and provide guidelines for the selection of carrier materials. We also discuss the combination of MDD technologies with classic medical devices to create multifunctional MDD devices that improve integration with host tissue, and the use of MDD technology in tissue-engineering strategies to direct cell behaviour. As our ever-expanding knowledge of human biology and disease provides new therapeutic targets that require precise control over their application, the importance of MDD devices in medicine is expected to increase.

[1]  Klaus Mosbach,et al.  Drug assay using antibody mimics made by molecular imprinting , 1993, Nature.

[2]  L. Chandler,et al.  Adenovirus encoding human platelet-derived growth factor-B delivered in collagen exhibits safety, biodistribution, and immunogenicity profiles favorable for clinical use. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  D J Mooney,et al.  Alginate hydrogels as synthetic extracellular matrix materials. , 1999, Biomaterials.

[4]  K. Smetana Cell biology of hydrogels. , 1993, Biomaterials.

[5]  Gregg W. Stone,et al.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease , 2004 .

[6]  David J Mooney,et al.  Cell delivery mechanisms for tissue repair. , 2008, Cell stem cell.

[7]  P. Janmey,et al.  Fibrin gels and their clinical and bioengineering applications , 2009, Journal of The Royal Society Interface.

[8]  Eben Alsberg,et al.  Engineering growing tissues , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B Mattiasson,et al.  'Smart' polymers and what they could do in biotechnology and medicine. , 1999, Trends in biotechnology.

[10]  David J Mooney,et al.  Effects of VEGF temporal and spatial presentation on angiogenesis. , 2010, Biomaterials.

[11]  Philip R. Kuhl,et al.  Tethered epidermal growth factor as a paradigm for growth factor–induced stimulation from the solid phase , 1996, Nature Medicine.

[12]  Robert Langer,et al.  First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip , 2012, Science Translational Medicine.

[13]  Guixue Wang,et al.  The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents. , 2011, Journal of vascular surgery.

[14]  C. Alvarez‐Lorenzo,et al.  Controlling drug release from imprinted hydrogels by modifying the characteristics of the imprinted cavities. , 2005, Macromolecular bioscience.

[15]  J. M. Badura,et al.  A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE® Bone Graft) , 2007, International Orthopaedics.

[16]  D. Mooney,et al.  Decoupling the dependence of rheological/mechanical properties of hydrogels from solids concentration , 2002 .

[17]  J. Jansen,et al.  Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivo. , 2005, Journal of biomedical materials research. Part A.

[18]  J. Leroux,et al.  Novel injectable neutral solutions of chitosan form biodegradable gels in situ. , 2000, Biomaterials.

[19]  Patrick Couvreur,et al.  Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.

[20]  Bradley K Weiner,et al.  A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. , 2011, The spine journal : official journal of the North American Spine Society.

[21]  Takashi Miyata,et al.  A reversibly antigen-responsive hydrogel , 1999, Nature.

[22]  K W Anderson,et al.  Cell-interactive Alginate Hydrogels for Bone Tissue Engineering , 2001, Journal of dental research.

[23]  R Langer,et al.  Laminated three-dimensional biodegradable foams for use in tissue engineering. , 1993, Biomaterials.

[24]  A. Pandit,et al.  The effect of TGF-beta delivered through a collagen scaffold on wound healing. , 1999, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[25]  Jennifer L. West,et al.  Tethered-TGF-β increases extracellular matrix production of vascular smooth muscle cells , 2001 .

[26]  A. Landesberg,et al.  Improved vascular organization enhances functional integration of engineered skeletal muscle grafts , 2011, Proceedings of the National Academy of Sciences.

[27]  N. Peppas,et al.  Transport of ionizable drugs and proteins in crosslinked poly(acrylic acid) and poly(acrylic acid-co-2-hydroxyethyl methacrylate) hydrogels. II. Diffusion and release studies , 1997 .

[28]  M. Spector,et al.  Healing of canine articular cartilage defects treated with microfracture, a type‐II collagen matrix, or cultured autologous chondrocytes , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[29]  E. L. Crossley A GENERAL REVIEW , 1954 .

[30]  A. Vaccaro,et al.  Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion , 2007, International Orthopaedics.

[31]  M. Kocher,et al.  Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up. , 2003, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[32]  B. Feeley,et al.  Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[33]  H. V. von Recum,et al.  Affinity-based drug delivery. , 2011, Macromolecular bioscience.

[34]  J. Fiorellini,et al.  Vertical ridge augmentation by means of deproteinized bovine bone block and recombinant human platelet-derived growth factor-BB: a histologic study in a dog model. , 2006, The International journal of periodontics & restorative dentistry.

[35]  A. M. Turing,et al.  The chemical basis of morphogenesis , 1952, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences.

[36]  David J Mooney,et al.  Alginate hydrogels as biomaterials. , 2006, Macromolecular bioscience.

[37]  Paul D. Kessler,et al.  Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.

[38]  A. Khademhosseini,et al.  Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[39]  K. Anseth,et al.  Photopolymerization of multilaminated poly(HEMA) hydrogels for controlled release. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[40]  M. Hadamitzky,et al.  Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial. , 2011, Journal of the American College of Cardiology.

[41]  Johnny Huard,et al.  Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. , 2002, The Journal of clinical investigation.

[42]  Yoshihiro Ito,et al.  Covalently immobilized biosignal molecule materials for tissue engineering. , 2007, Soft matter.

[43]  David J. Mooney,et al.  Infection-Mimicking Materials to Program Dendritic Cells In Situ , 2008, Nature materials.

[44]  F. Eberli,et al.  Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial , 2011, The Lancet.

[45]  Y. Tabata,et al.  Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. , 2003, Biomaterials.

[46]  L Claes,et al.  VEGF producing bone marrow stromal cells (BMSC) enhance vascularization and resorption of a natural coral bone substitute. , 2007, Bone.

[47]  W. Pitt,et al.  Ultrasonic drug delivery – a general review , 2004, Expert opinion on drug delivery.

[48]  Y. Ikada,et al.  Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. , 2000, Biomaterials.

[49]  Hans-Günther Machens,et al.  Use of human mesenchymal cells to improve vascularization in a mouse model for scaffold-based dermal regeneration. , 2009, Tissue engineering. Part A.

[50]  Antonios G. Mikos,et al.  Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. , 2007, Biomaterials.

[51]  Horst Kessler,et al.  RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. , 2003, Biomaterials.

[52]  J. Hirsh,et al.  Heparin Binding Proteins Contribution to Heparin Rebound After Cardiopulmonary Bypass , 1993, Circulation.

[53]  P. Hammond Form and Function in Multilayer Assembly: New Applications at the Nanoscale , 2004 .

[54]  D. Hutmacher,et al.  In vivo mesenchymal cell recruitment by a scaffold loaded with transforming growth factor beta1 and the potential for in situ chondrogenesis. , 2002, Tissue engineering.

[55]  Robert Langer,et al.  INVITED REVIEW POLYMERIC DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE , 1980 .

[56]  Dean-Mo Liu,et al.  Magnetic-sensitive behavior of intelligent ferrogels for controlled release of drug. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[57]  H. V. von Recum,et al.  Cyclodextrin-based device coatings for affinity-based release of antibiotics. , 2010, Biomaterials.

[58]  Robert J Fisher,et al.  Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. , 2006, Biomaterials.

[59]  D. Kim,et al.  Vertical ridge augmentation using an equine block infused with recombinant human platelet-derived growth factor-BB: a histologic study in a canine model. , 2009, The International journal of periodontics & restorative dentistry.

[60]  L. Gibson,et al.  The effect of pore size on cell adhesion in collagen-GAG scaffolds. , 2005, Biomaterials.

[61]  Jeff W Lichtman,et al.  Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors , 2009, Proceedings of the National Academy of Sciences.

[62]  D. Mooney,et al.  Growth factor delivery-based tissue engineering: general approaches and a review of recent developments , 2011, Journal of The Royal Society Interface.

[63]  Jeffrey W Moses,et al.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.

[64]  K. Shakesheff,et al.  Polymeric systems for controlled drug release. , 1999, Chemical reviews.

[65]  L. Lavery,et al.  The costs of diabetic foot: the economic case for the limb salvage team. , 2010, Journal of the American Podiatric Medical Association.

[66]  D. M. Lynn,et al.  Controlling interlayer diffusion to achieve sustained, multiagent delivery from layer-by-layer thin films , 2006, Proceedings of the National Academy of Sciences.

[67]  C. Laurencin,et al.  Bone tissue engineering by gene delivery. , 2006, Advanced drug delivery reviews.

[68]  P. Gupta,et al.  Hydrogels: from controlled release to pH-responsive drug delivery. , 2002, Drug discovery today.

[69]  H. Vandenburgh,et al.  The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regeneration. , 2011, Biomaterials.

[70]  Matthias P. Lutolf,et al.  Designing materials to direct stem-cell fate , 2009, Nature.

[71]  R Langer,et al.  Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. , 1985, Journal of Biomedical Materials Research.

[72]  T J Roseman,et al.  Release of steroids from a silicone polymer. , 1972, Journal of pharmaceutical sciences.

[73]  A. Schulz,et al.  Mid-term results of Autologous Matrix-Induced Chondrogenesis for treatment of focal cartilage defects in the knee , 2010, Knee Surgery, Sports Traumatology, Arthroscopy.

[74]  Jiyoung M Dang,et al.  Natural polymers for gene delivery and tissue engineering. , 2006, Advanced drug delivery reviews.

[75]  R. Erbel,et al.  Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[76]  Vladimir Mironov,et al.  Organ printing: computer-aided jet-based 3D tissue engineering. , 2003, Trends in biotechnology.

[77]  M. Einarson Controlled-release microchip , 1999, Nature Biotechnology.

[78]  Daniel Scherman,et al.  Growth factor delivery approaches in hydrogels. , 2009, Biomacromolecules.

[79]  A. Sun,et al.  Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. , 1996, The Journal of clinical investigation.

[80]  Miqin Zhang,et al.  Chitosan-based hydrogels for controlled, localized drug delivery. , 2010, Advanced drug delivery reviews.

[81]  David J Mooney,et al.  Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. , 2005, Biomaterials.

[82]  Daniel G. Anderson,et al.  Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain. , 2011, Endocrine reviews.

[83]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[84]  D E Ingber,et al.  Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. , 1993, Journal of biomedical materials research.

[85]  J. Hubbell,et al.  Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering , 2005, Nature Biotechnology.

[86]  R. Tuan,et al.  Technology Insight: adult mesenchymal stem cells for osteoarthritis therapy , 2008, Nature Clinical Practice Rheumatology.

[87]  R. Langer,et al.  Polymers for the sustained release of proteins and other macromolecules , 1976, Nature.

[88]  Peter X. Ma,et al.  Nanofibrous hollow microspheres self-assembled from star-shaped polymers as injectable cell carriers for knee repair , 2011, Nature materials.

[89]  Yoshimitsu Kuroyanagi,et al.  Design of artificial skin , 1996 .

[90]  Eben Alsberg,et al.  Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. , 2004, Bone.

[91]  Franz E Weber,et al.  Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. , 2005, Biotechnology and bioengineering.

[92]  T. Guda,et al.  Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release. , 2011, Tissue engineering. Part A.

[93]  A. Concheiro,et al.  Molecularly imprinted polymers for drug delivery. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[94]  J. Kost,et al.  Ultrasound-enhanced polymer degradation and release of incorporated substances. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[95]  M. Ferguson,et al.  Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration , 2007, Journal of The Royal Society Interface.

[96]  J. Hubbell,et al.  Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. , 1999, Bioconjugate chemistry.

[97]  M. Cima,et al.  Mechanical properties of dense polylactic acid structures fabricated by three dimensional printing. , 1996, Journal of biomaterials science. Polymer edition.

[98]  I. Yannas,et al.  Design of an artificial skin. I. Basic design principles. , 1980, Journal of biomedical materials research.

[99]  S. Santavirta,et al.  Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients , 2002, The Journal of bone and joint surgery. American volume.

[100]  A. Kundu,et al.  Adhesion of mesenchymal stem cells to polymer scaffolds occurs via distinct ECM ligands and controls their osteogenic differentiation. , 2006, Journal of biomedical materials research. Part A.

[101]  R. Fisher,et al.  Human hepatocyte transplantation: worldwide results. , 2006, Transplantation.

[102]  Dietmar W Hutmacher,et al.  Current strategies for cell delivery in cartilage and bone regeneration. , 2004, Current opinion in biotechnology.

[103]  Charles A. Vacanti,et al.  Transplantation of Chondrocytes Utilizing a Polymer‐Cell Construct to Produce Tissue‐Engineered Cartilage in the Shape of a Human Ear , 1997, Plastic and reconstructive surgery.

[104]  A. Metters,et al.  Hydrogels in controlled release formulations: network design and mathematical modeling. , 2006, Advanced drug delivery reviews.

[105]  R Langer,et al.  Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. , 1996, Biomaterials.

[106]  Paula T Hammond,et al.  Electroactive controlled release thin films , 2008, Proceedings of the National Academy of Sciences.

[107]  R. Colvin,et al.  Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[108]  B. Blumenthal,et al.  Polyurethane scaffolds seeded with genetically engineered skeletal myoblasts: a promising tool to regenerate myocardial function. , 2010, Artificial organs.

[109]  Robert Langer,et al.  Progress in the tissue engineering and stem cell industry "are we there yet?". , 2012, Tissue engineering. Part B, Reviews.

[110]  A. Ganser,et al.  Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium , 2005, Circulation.

[111]  David J. Mooney,et al.  Active scaffolds for on-demand drug and cell delivery , 2010, Proceedings of the National Academy of Sciences.

[112]  J. Hubbell,et al.  Bioactive biomaterials. , 1999, Current opinion in biotechnology.

[113]  M. Sefton,et al.  Tissue engineering. , 1998, Journal of cutaneous medicine and surgery.

[114]  Smadar Cohen,et al.  The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. , 2008, Biomaterials.

[115]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[116]  I. Yannas,et al.  Organized skin structure is regenerated in vivo from collagen-GAG matrices seeded with autologous keratinocytes. , 1998, The Journal of investigative dermatology.

[117]  S. Boden,et al.  THE USE OF BMP-2 IN INTERBODY FUSION CAGES: DEFINITIVE EVIDENCE OF OSTEOINDUCTION IN HUMANS , 2002 .

[118]  Gabriela A Silva,et al.  Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. , 2007, Advanced drug delivery reviews.

[119]  Masanori Fujita,et al.  Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. , 2003, Journal of biomedical materials research. Part A.

[120]  Paula T Hammond,et al.  Tissue integration of growth factor-eluting layer-by-layer polyelectrolyte multilayer coated implants. , 2011, Biomaterials.

[121]  Daniel Anderson,et al.  Delivery materials for siRNA therapeutics. , 2013, Nature materials.

[122]  Anthony Atala,et al.  De novo reconstitution of a functional mammalian urinary bladder by tissue engineering , 1999, Nature Biotechnology.

[123]  A. Khademhosseini,et al.  Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology , 2006 .

[124]  Hideo Tanaka,et al.  Diffusion characteristics of substrates in Ca‐alginate gel beads , 1984, Biotechnology and bioengineering.

[125]  Eun-Suk Kim,et al.  Material-based deployment enhances efficacy of endothelial progenitor cells , 2008, Proceedings of the National Academy of Sciences.

[126]  David J Mooney,et al.  In Situ Regulation of DC Subsets and T Cells Mediates Tumor Regression in Mice , 2009, Science Translational Medicine.

[127]  D. Kohane,et al.  HYDROGELS IN DRUG DELIVERY: PROGRESS AND CHALLENGES , 2008 .

[128]  N. Peppas,et al.  Transport of ionizable drugs and proteins in crosslinked poly(acrylic acid) and poly(acrylic acid-co-2-hydroxyethyl methacrylate) hydrogels. I. Polymer characterization , 1996 .

[129]  M L Cooper,et al.  In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. , 1991, Biomaterials.

[130]  A. Rachkov,et al.  Towards molecularly imprinted polymers selective to peptides and proteins. The epitope approach. , 2001, Biochimica et biophysica acta.

[131]  S. Boden,et al.  The Use of rhBMP-2 in Interbody Fusion Cages: Definitive Evidence of Osteoinduction in Humans: A Preliminary Report , 2000, Spine.

[132]  Patrick W Serruys,et al.  Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[133]  E. Edelman,et al.  Physiological Transport Forces Govern Drug Distribution for Stent-Based Delivery , 2001, Circulation.

[134]  D J Mooney,et al.  Open pore biodegradable matrices formed with gas foaming. , 1998, Journal of biomedical materials research.

[135]  V. Goldberg,et al.  Ectopic induction of cartilage and bone by water-soluble proteins from bovine bone using a polyanhydride delivery vehicle. , 1989, Journal of biomedical materials research.

[136]  Robert Langer,et al.  Synthesis and RGD peptide modification of a new biodegradable copolymer: poly(lactic acid-co-lysine) , 1993 .

[137]  Hai Yao,et al.  Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study , 2010, The Lancet.

[138]  Ulrich Kneser,et al.  Injectable liver: a novel approach using fibrin gel as a matrix for culture and intrahepatic transplantation of hepatocytes. , 2005, Tissue engineering.

[139]  A. Schindler,et al.  Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters. , 1979, Journal of pharmaceutical sciences.

[140]  Darrell J Irvine,et al.  Engineering synthetic vaccines using cues from natural immunity. , 2013, Nature materials.

[141]  W. Hunter,et al.  Drug-eluting stents: a multidisciplinary success story. , 2006, Advanced drug delivery reviews.

[142]  Jing Zhang,et al.  Synthesis and Characterization of pH- and Temperature-Sensitive Poly(methacrylic acid)/Poly(N-isopropylacrylamide) Interpenetrating Polymeric Networks , 2000 .

[143]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[144]  K. Sawahata,et al.  Electrically controlled drug delivery system using polyelectrolyte gels , 1990 .

[145]  U Kneser,et al.  Long-term differentiated function of heterotopically transplanted hepatocytes on three-dimensional polymer matrices. , 1999, Journal of biomedical materials research.

[146]  Marc Hedrick,et al.  Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. , 2005, Tissue engineering.

[147]  R. Loeser Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. , 2009, Osteoarthritis and cartilage.

[148]  Sanjay Garg,et al.  Advanced drug-delivery systems , 2011 .

[149]  T. Chang Artificial liver support based on artificial cells with emphasis on encapsulated hepatocytes. , 2008, Artificial organs.

[150]  S. Murdan Electro-responsive drug delivery from hydrogels. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[151]  S. Davis,et al.  In vitro evaluation of alginate gel systems as sustained release drug delivery systems , 1986 .

[152]  J. Vacanti,et al.  Biodegradable sponges for hepatocyte transplantation. , 1995, Journal of biomedical materials research.

[153]  H. Vandenburgh,et al.  Tissue-engineered skeletal muscle organoids for reversible gene therapy. , 1996, Human gene therapy.

[154]  S. Bryant,et al.  Cell encapsulation in biodegradable hydrogels for tissue engineering applications. , 2008, Tissue engineering. Part B, Reviews.

[155]  Antonios G Mikos,et al.  Gelatin as a delivery vehicle for the controlled release of bioactive molecules. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[156]  D. Mooney,et al.  Combined Angiogenic and Osteogenic Factor Delivery Enhances Bone Marrow Stromal Cell‐Driven Bone Regeneration , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[157]  R. Virmani,et al.  Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus‐eluting stents in a porcine model of restenosis , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[158]  David J Mooney,et al.  An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. , 2011, Biomaterials.

[159]  David J Mooney,et al.  Mimicking nature by codelivery of stimulant and inhibitor to create temporally stable and spatially restricted angiogenic zones , 2010, Proceedings of the National Academy of Sciences.

[160]  Allan S. Hoffman,et al.  The origins and evolution of "controlled" drug delivery systems. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[161]  W. Harris,et al.  Biologic fixation of total hip implants. Insights gained from a series of canine studies. , 2004, The Journal of bone and joint surgery. American volume.

[162]  L. Lavery,et al.  The costs of diabetic foot: the economic case for the limb salvage team. , 2010, Journal of vascular surgery.

[163]  G. Hsiue,et al.  Heterobifunctional poly(ethylene glycol)-tethered bone morphogenetic protein-2-stimulated bone marrow mesenchymal stromal cell differentiation and osteogenesis. , 2007, Tissue engineering.

[164]  Cato T Laurencin,et al.  Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: A combined gene therapy–cell transplantation approach , 2008, Proceedings of the National Academy of Sciences.

[165]  N. Peppas,et al.  Hydrogels in Pharmaceutical Formulations , 1999 .

[166]  J. Hubbell,et al.  Development of growth factor fusion proteins for cell‐triggered drug delivery , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.